Springer Pathogenicity and Drug Resistance of Human Pathogens: Mechanisms and Novel Approaches

Product Description The book comprehensively discusses the mechanisms of pathogenesis and drug resistance; current diagnostics landscape of four key human pathogens; bacterial, fungal, protozoans and viral which are the causes of major infectious diseases. It also assesses the emerging technologies for the detection and quantification of these pathogens. Further, it discusses the novel opportunities to fight against these infectious diseases and to identify pertinent drug targets with novel methodologies. It also reviews the current and future insights into the control, elimination, and eradication of these infectious diseases. Importantly, the book discusses the epidemiological characteristics and various challenges in combating Ebola and Influenza diseases. Finally, the book highlights the growing role of nanotechnology and bioinformatics resources for combating the infectious diseases. In summary, the book provides the mechanistic insight of the pathogenicity, drug-resistance, therapeutic strategies and identification of the novel drug targets of Mycobacterium tuberculosis, Plasmodium, Candida, Hepatitis C and emerging viral infections. From the Back Cover The book comprehensively discusses the mechanisms of pathogenesis and drug resistance; current diagnostics landscape of four key human pathogens; bacterial, fungal, protozoans and viral which are the causes of major infectious diseases. It also assesses the emerging technologies for the detection and quantification of these pathogens. Further, it discusses the novel opportunities to fight against these infectious diseases and to identify pertinent drug targets with novel methodologies. It also reviews the current and future insights into the control, elimination, and eradication of these infectious diseases. Importantly, the book discusses the epidemiological characteristics and various challenges in combating Ebola and Influenza diseases. Finally, the book highlights the growing role of nanotechnology and bioinformatics resources for combating the infectious diseases. In summary, the book provides the mechanistic insight of the pathogenicity, drug-resistance, therapeutic strategies and identification of the novel drug targets of Mycobacterium tuberculosis, Plasmodium, Candida, Hepatitis C and emerging viral infections. About the Author Dr. Saif Hameed is currently Associate Professor at Amity Institute of Biotechnology, Amity University Haryana. Dr. Hameed did his Bachelors from University of Delhi and Masters from Jamia Hamdard with distinction in 2003 and 2005 respectively. He completed his doctoral studies in Life Sciences from Jawaharlal Nehru University in 2010 where he also received CSIR Research Associateship for the one year postdoctoral work. He also worked as Visiting Scholar in Institute für Mikrobiologie, Heinrich-Heine-Universität, Düsseldorf, Germany in 2008. Dr. Hameed has received Young Scientist award from Science and Engineering Research Board, Department of Science and Technology, New Delhi in the year 2012. Dr. Hameed is actively engaged in research in the field of infectious diseases related to multidrug resistance (MDR) in pathogenic fungi. He has around 40 peer-reviewed papers to his credit in both international and national journals of repute, 2 books, 15 book chapters along with 22 popular articles with 2 of them as ‘cover story’. He has successfully convened 7 national conferences as Organizing Secretary. He has guided 2 Ph.D. students for their doctoral degrees and supervised 20 UG & PG level students for their research projects. He is life member of Association of Microbiologist of India (AMI) and International Society for Infectious Diseases (ISID).   Dr. Zeeshan Fatima is currently working as Associate Professor at Amity Institute of Biotechnology, Amity University Haryana. Dr. Fatima did her Bachelors and Masters from Banaras Hindu University in 2000 and 2002 respectively. She earned her doctoral degree i